AxoGen Inc
NASDAQ:AXGN
AxoGen Inc
Interest Income Expense
AxoGen Inc
Interest Income Expense Peer Comparison
Competitive Interest Income Expense Analysis
Latest Figures & CAGR of Competitors
Company | Interest Income Expense | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
AxoGen Inc
NASDAQ:AXGN
|
Interest Income Expense
-$2.1m
|
CAGR 3-Years
-19%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
8%
|
|
Becton Dickinson and Co
NYSE:BDX
|
Interest Income Expense
-$384m
|
CAGR 3-Years
9%
|
CAGR 5-Years
12%
|
CAGR 10-Years
-16%
|
|
Boston Scientific Corp
NYSE:BSX
|
Interest Income Expense
-$554m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-51%
|
CAGR 10-Years
-6%
|
|
Stryker Corp
NYSE:SYK
|
Interest Income Expense
$97m
|
CAGR 3-Years
7%
|
CAGR 5-Years
-7%
|
CAGR 10-Years
N/A
|
|
Abbott Laboratories
NYSE:ABT
|
Interest Income Expense
-$296m
|
CAGR 3-Years
16%
|
CAGR 5-Years
16%
|
CAGR 10-Years
-13%
|
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
Interest Income Expense
$227m
|
CAGR 3-Years
11%
|
CAGR 5-Years
19%
|
CAGR 10-Years
29%
|
See Also
What is AxoGen Inc's Interest Income Expense?
Interest Income Expense
-2.1m
USD
Based on the financial report for Mar 31, 2024, AxoGen Inc's Interest Income Expense amounts to -2.1m USD.
What is AxoGen Inc's Interest Income Expense growth rate?
Interest Income Expense CAGR 10Y
8%
The average annual Interest Income Expense growth rates for AxoGen Inc have been -19% over the past three years , and 8% over the past ten years .